Education
About Us
Working with TipRanks
Follow Us
Metlife (MET)
NYSE:MET
MET Stock Chart & Stats
$73.24
$0.03(0.04%)
At close: 4:00 PM EST
$73.24
$0.03(0.04%)
Day’s Range― - ―
52-Week Range$65.21 - $87.39
Previous CloseN/A
Volume1.32M
Average Volume (3M)3.93M
Market Cap
$47.76B
Enterprise Value$45.55B
Total Cash (Recent Filing)$22.03B
Total Debt (Recent Filing)$19.33B
Price to Earnings (P/E)15.3
Beta0.95
Next Earnings
May 06, 2026EPS Estimate
2.2Next Dividend Ex-DateN/A
Dividend Yield2.78%
Share Statistics
EPS (TTM)2.49
Shares Outstanding652,053,900
10 Day Avg. Volume3,831,967
30 Day Avg. Volume3,925,618
Financial Highlights & Ratios
PEG Ratio-0.79
Price to Book (P/B)1.85
Price to Sales (P/S)0.68
P/FCF Ratio18.48
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue0.60
Enterprise Value/Gross Profit2.34
Enterprise Value/Ebitda7.96
Forecast
1Y Price Target
$93.50Price Target Upside27.66% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)9.82
Revenue Forecast (FY)$79.06B
Bulls Say, Bears Say
Bulls Say
Cash Flow And Return ExpansionHigh and improving free cash flow conversion as the business mix shifts should support return on equity expansion and fund strategic priorities.
Market Position And Share GainsLeadership in group benefits and institutional retirement positions the company to capture market share in growing sectors and drive revenue expansion.
Segment Separation ValuationSeparating MetLife Investment Management into a distinct segment could create a valuation arbitrage by making asset management results more visible to investors.
Bears Say
Analyst Sentiment And Earnings OutlookAnalyst downgrade combined with expectations of downside to forward earnings may reduce investor confidence and put downward pressure on the share price.
Credit And Commercial Real Estate ExposureLow yields on newly issued corporate debt alongside a relatively higher-risk commercial mortgage loan portfolio could pressure valuation if credit spreads widen or commercial real estate weakens.
Relative Valuation RiskThe stock trading expensive versus many mid-cap peers suggests limited upside and greater vulnerability to profit disappointments.
Metlife News
MET FAQ
What was Metlife’s price range in the past 12 months?
Metlife lowest stock price was $65.21 and its highest was $87.39 in the past 12 months.
What is Metlife’s market cap?
Metlife’s market cap is $47.76B.
When is Metlife’s upcoming earnings report date?
Metlife’s upcoming earnings report date is May 06, 2026 which is in 64 days.
How were Metlife’s earnings last quarter?
Metlife released its earnings results on Feb 04, 2026. The company reported $2.49 earnings per share for the quarter, beating the consensus estimate of $2.336 by $0.154.
Is Metlife overvalued?
According to Wall Street analysts Metlife’s price is currently Undervalued.
Does Metlife pay dividends?
Metlife pays a Quarterly dividend of $0.568 which represents an annual dividend yield of 2.78%. See more information on Metlife dividends here
What is Metlife’s EPS estimate?
Metlife’s EPS estimate is 2.2.
How many shares outstanding does Metlife have?
Metlife has 652,053,900 shares outstanding.
What happened to Metlife’s price movement after its last earnings report?
Metlife reported an EPS of $2.49 in its last earnings report, beating expectations of $2.336. Following the earnings report the stock price went down -3.448%.
Which hedge fund is a major shareholder of Metlife?
Currently, no hedge funds are holding shares in MET
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Metlife Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$93.50 (27.66% Upside)
$93.50 (27.66% Upside)
Blogger Sentiment
Bullish
MET Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 120.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.70%
12-Months-Change
Fundamentals
Return on Equity
12.10%
Trailing 12-Months
Asset Growth
9.99%
Trailing 12-Months
Company Description
Metlife
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
MET Company Deck
MET Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong operational momentum across multiple businesses, robust top-line growth, successful strategic actions (PineBridge, reinsurance, PRT origination) and achievement of key 2025 targets (adjusted EPS growth, ROE, expense efficiency, and free cash flow progress). Primary near-term concerns include a modest shortfall in variable investment income (and slightly lower-than-expected private equity/real estate returns), an anticipated 2026 drag from corporate & other, a temporary rise in the direct expense ratio due to the PineBridge acquisition, and some line-specific underwriting pressure (disability). Taken together, the positives — including record PRT origination, strong regional sales, AUM growth, capital returns, and adherence to strategic commitments — materially outweigh the headwinds described, supporting a constructive outlook.View all MET earnings summariesMET Stock 12 Month Forecast
Average Price Target
$93.50
▲(27.66% Upside)
Technical Analysis
Ownership Overview
0.27% Insiders
26.06% Mutual Funds
8.52% Other Institutional Investors
43.55% Public Companies and
Individual Investors